Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | LTA4H | P09960 | 2/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.37 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 6/20 | 0.36 |
| ▸ | PPARA | Q07869 | 6/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28583037 | 0.81 | TRPA1 (0.46) | LMNAALDH1A1LTA4HMTNR1AMTNR1B | |
| SCHEMBL11612204 | 0.79 | LMNA (0.57) | LMNAALDH1A1RECQLMTNR1AMTNR1B | |
| SCHEMBL8187182 | 0.79 | LMNA (0.47) | LMNAALDH1A1RECQLCA4MTNR1A | |
| SCHEMBL29164280 | 0.79 | LMNA (0.38) | LMNAALDH1A1RECQLLTA4HCA4 | |
| SCHEMBL31591455 | 0.79 | LMNA (0.38) | LMNAALDH1A1RECQLLTA4HCA4 | |
| SCHEMBL18346393 | 0.78 | LMNA (0.37) | LMNAALDH1A1RECQLLTA4HCA4 | |
| SCHEMBL27906584 | 0.78 | SLC6A4 (0.39) | LMNAALDH1A1RECQLLTA4HMTNR1A | |
| SCHEMBL13743571 | 0.78 | SLC6A4 (0.39) | LMNAALDH1A1RECQLLTA4HMTNR1A | |
| SCHEMBL19309368 | 0.77 | LMNA (0.43) | LMNAALDH1A1RECQLLTA4HMTNR1A | |
| SCHEMBL242390 | 0.77 | LMNA (0.43) | LMNAALDH1A1RECQLLTA4HMTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111686018-A | Formula and preparation method of anti-blue-light isolation emulsion | 广州欧卡娜化妆品有限公司 | 2020-09-22 | — | — | CN | claimed |
| CN-111480926-A | A adsorption structure and makeup ornaments for making up ornaments | 鞍山欣晟美容品有限公司 | 2020-08-04 | — | — | CN | claimed |
| US-20250344693-A1 | HERBICIDE SUSPENSION CONCENTRATES AND METHOD FOR THEIR PREPARATION | NUFARM AUSTRALIA LTD (AU) | 2025-11-13 | — | — | US | disclosed |
| CN-118845501-B | Hydrophobic oleophylic skin-friendly ultrafine powder and preparation method and application thereof | 广州晋航生物科技有限公司 | 2025-04-15 | — | — | CN | disclosed |
| EP-4514130-A1 | HERBICIDE SUSPENSION CONCENTRATES AND METHOD FOR THEIR PREPARATION | Nufarm Australia Limited (AU) | 2025-03-05 | — | — | EP | disclosed |
| WO-2023205845-A1 | HERBICIDE SUSPENSION CONCENTRATES AND METHOD FOR THEIR PREPARATION | NUFARM AUSTRALIA LIMITED (AU) | 2023-11-02 | — | — | WO | disclosed |
| CN-115844745-A | Anti-wrinkle composition, application thereof and cosmetic | 广州旭妆生物科技有限公司 | 2023-03-28 | — | — | CN | disclosed |
| CN-111686018-A | Formula and preparation method of anti-blue-light isolation emulsion | 广州欧卡娜化妆品有限公司 | 2020-09-22 | — | — | CN | disclosed |
| CN-111686018-A | Formula and preparation method of anti-blue-light isolation emulsion | 广州欧卡娜化妆品有限公司 | 2020-09-22 | — | — | CN | disclosed |
| CN-111480926-A | A adsorption structure and makeup ornaments for making up ornaments | 鞍山欣晟美容品有限公司 | 2020-08-04 | — | — | CN | disclosed |
| CN-1309563-B | Use of 1-(aminoalkyl)-3-quinoxaline-2-one derives for preparation of compounds having antioxidant action | PHAFAG AG | 2012-06-06 | — | — | CN | disclosed |
| EP-1087768-B1 | USE OF 1-(AMINOALKYL)-3-QUINOXALINE-2-ONE DERIVATIVES FOR THE PREPARATION OF COMPOUNDS HAVING AN ANTIOXIDANT ACTION | PHAFAG AG (LI) | 2009-01-14 | — | — | EP | disclosed |
| US-6573265-B2 | Preventing or treating diseases caused by free radicals of the cellular oxygen metabolism, stimulating nerve cell growth, antagonizing glutamate receptors and/or stimulating the growth notably of glutamergic nerve cells; anticarcinogenic agents; | PHAFAG AKTIENGESELLSCHAFT (LI) | 2003-06-03 | — | — | US | disclosed |
| CN-1309563-A | Use of 1-(aminoalkyl)-3-quinoxaline-2-one derives for preparation of compounds having antioxidant action | PHAFAG AG (LI) | 2001-08-22 | — | — | CN | disclosed |
| US-20010006966-A1 | Use of 1- (aminoalkyl) -3-quinoxaline-2-on derivatives for the preparation of compounds having an antioxidant action | PHAFAG AKTIENGESELLSCHAFT (LI) | 2001-07-05 | — | — | US | disclosed |
| EP-1087768-A1 | USE OF 1-(AMINOALKYL)-3-QUINOXALINE-2-ONE DERIVATIVES FOR THE PREPARATION OF COMPOUNDS HAVING AN ANTIOXIDANT ACTION | PHAFAG AKTIENGESELLSCHAFT (LI) | 2001-04-04 | — | — | EP | disclosed |
| US-6171368-B1 | APPARATUS AND AN ASSOCIATED METHOD OF OPERATION FOR REMOVAL OF GASEOUS CONTAMINANTS, PARTICULARLY OXYGEN, FROM CLOSED CONTAINERS | MED-E-CELL | 2001-01-09 | — | — | US | disclosed |
| WO-2000027727-A1 | METHOD AND DEVICE FOR STORING ARTICLES UNDER CONTROLLED ATMOSPHERE | MED-E-CELL (US) | 2000-05-18 | — | — | WO | disclosed |
| WO-1999066931-A1 | USE OF 1-(AMINOALKYL)-3-QUINOXALINE-2-ONE DERIVATIVES FOR THE PREPARATION OF COMPOUNDS HAVING AN ANTIOXIDANT ACTION | PHAFAG AKTIENGESELLSCHAFT (LI) | 1999-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010006966-A1 | Use of 1- (aminoalkyl) -3-quinoxaline-2-on derivatives for the preparation of compounds having an antioxidant action | GLS, GLUL, GLS2 | LMNA 4220/4885ALDH1A1 453/4885RECQL 1201/4885 |
| US-20250344693-A1 | HERBICIDE SUSPENSION CONCENTRATES AND METHOD FOR THEIR PREPARATION | DDT, CDC25C, MTX2 | LMNA 4300/4885ALDH1A1 619/4885RECQL 1525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.